Position in VRDN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,579,422
+$2,120,585 QoQ
Shares Held
140,415
+498.6% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 215 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Derivatives in VRDN
reported options exposure · as of Mar 31, 2023CallValue
$763,200
CallShares
30,000
PutValue
$763,200
PutShares
30,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. VRDN ranks #97 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in VRDN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,579,422 | 140,415 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $458,837 | 23,458 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $494,278 | 15,883 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $143,333 | 6,642 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $601,027 | 42,992 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,825,380 | 135,414 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,605,603 | 135,921 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,051,436 | 46,217 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $353,910 | 27,203 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $6,091,956 | 347,913 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,835,770 | 84,287 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,692,140 | 110,309 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $1,897,132 | 79,745 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $763,200 | 30,000 | Call | Defined | 2023-05-11 | |
| 2023-03-31 | $763,200 | 30,000 | Put | Defined | 2023-05-11 | |
| 2023-03-31 | $4,276,489 | 168,101 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,675,339 | 57,355 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $1,094,782 | 53,378 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $21,566 | 1,864 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $520,308 | 28,140 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $294,256 | 14,884 | Shares | Defined | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||